首页> 美国政府科技报告 >Physiologically Based Pharmacokinetic Model for 2,3,7,8-Tetrabromodibenzo-p-Dioxin (TBDD) in the Rat: Tissue Distribution and CYP1A Induction
【24h】

Physiologically Based Pharmacokinetic Model for 2,3,7,8-Tetrabromodibenzo-p-Dioxin (TBDD) in the Rat: Tissue Distribution and CYP1A Induction

机译:基于生理学的大鼠2,3,7,8-四溴二苯并二恶英(TBDD)药代动力学模型:组织分布和CYp1a诱导

获取原文

摘要

Biologically based models serve as valuable tools for integration of mechanistic pharmacokinetic data by their explicit definition of important determinants of chemical disposition. The objective of the present work was to develop a physiologically based pharmacokinetic model to describe the disposition and enzyme induction properties of 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD). The TBDD model, which was based on models previously developed for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), incorporated: ternary interactions between TBDD, the Ah receptor, and specific DNA-binding sites; induction of a TBDD-binding protein specific to the liver; and diffusion-limited tissue uptake. (Copyright (c) 1993 by Academic Press, Inc.)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号